Anti-VHH Affinity Magnetic Beads – Catalog #B2026670

Anti-VHH Affinity Magnetic Beads (Catalog #B2026670) combine superparamagnetic particles with high-affinity antibodies targeting VHH (variable domains of heavy-chain-only antibodies). VHHs, also known as nanobodies, are single-domain antibodies (12–15 kDa) derived from camelids. They are powerful tools in research and therapeutic development due to their small size, high thermal stability, and ease of engineering. These magnetic beads facilitate rapid purification of VHH clones from selection campaigns and expression systems.

Scientific Overview

VHH domains are the antigen-binding fragments derived from camelid heavy-chain-only antibodies. Unlike conventional antibodies (four chains), VHHs are single polypeptide chains (~12 kDa), offering distinct advantages: exceptional thermal stability (many VHHs retain binding above 80°C), high solubility, compact size enabling tissue penetration, and direct expression in bacteria or yeast. They are commonly selected from large libraries (>10¹³ clones) by phage or yeast display.

Magnetic bead-based affinity purification is a standard method for VHH selection and enrichment. Anti-VHH antibodies recognize conserved framework regions on all VHHs, providing universal capture. The magnetic format enables rapid, hands-on-free selection: incubate the display library with target-bound to beads, wash away non-binders, and recover VHH-displaying phage or yeast cells.

Key applications include:

• VHH library selection against protein targets and cell-surface antigens
• Immunoaffinity purification of recombinant VHH-fusion proteins
• Capture of VHH-displaying phage during panning
• Enrichment of VHH-functionalized particles (e.g., extracellular vesicles, nanoparticles)

Usage & Handling Guidance

Resuspend beads gently (do not vortex) before use. For phage display selection: coat beads with antigen or target protein, add phage display library, incubate with gentle rotation, wash thoroughly with PBS + 0.05% Tween-20, and recover bound phage by elution (low pH, protease, or dissociation buffer). For protein purification: incubate beads with VHH-containing sample, wash, and elute with imidazole (if His-tagged) or low pH buffer.

• Binding: Room temperature to 4°C; optimize incubation time based on target concentration (typically 15 min to 2 hours).
• Washing: Use PBS + 0.05–0.1% Tween-20 or other mild detergents to reduce non-specific binding.
• Elution: Low pH (0.1 M HCl or glycine–HCl pH 2.2), 200–500 mM imidazole (for His tags), or protease cleavage depending on VHH format.

What You Get

• 2 mL of anti-VHH magnetic beads, ready to use
• High-affinity capture of VHH domains
• Magnetic separation eliminates centrifugation
• Scalable for library selection or recombinant protein purification
• For research use only (RUO)

Why Researchers Choose It

• Universal capture of all VHH clones from diverse libraries
• Rapid, equipment-free selection enabling high-throughput campaigns
• Minimal sample loss due to magnetic handling
• Suitable for both selection and downstream purification workflows

Frequently Asked Questions (FAQ)

• Do these beads work for all VHH origins?
  Yes. Anti-VHH antibodies recognize conserved VHH framework regions, so they capture VHHs from alpacas, llamas, sharks, and other sources used in display libraries.
• Can I use these beads for yeast display selection?
  Yes. Coat the beads with antigen, add yeast-display library, incubate, wash, and recover VHH-displaying yeast cells by plating on selective medium.
• What is the beads' binding capacity?
  Capacity depends on VHH concentration and size. Typically, 50–100 µL of beads can capture 1–10 µg of VHH protein; optimize for your specific target.
• How do I prevent non-specific binding?
  Include 0.5–1% BSA or casein in binding buffer, and use 0.05–0.1% Tween-20 in wash buffers.
• Can I re-use the beads?
  After thorough washing and elution, beads can be regenerated and reused; however, some loss of binding capacity may occur with repeated cycles.
• What is the typical recovery of VHHs?
  Recovery depends on binding conditions and elution method. Under optimized conditions, 50–90% recovery is typical for affinity-based selection.

References

• Terzić J, Filipović L, Mitić N, Stevanović S, Krstić J, de Marco A, Courraud J, Popović M. Application of VHH-Immobilized Cryogel-Based Immunoaffinity Chromatography for Isolation of Extracellular Vesicles. Molecules. 2025;30(22).
• Filipović L, Spasojević M, Prodanović R, Korać A, Matijaševic S, Brajušković G, de Marco A, Popović M. Affinity-based isolation of extracellular vesicles by means of single-domain antibodies bound to macroporous methacrylate-based copolymer. N Biotechnol. 2022;69:36-48.
• Zhu M, Gong X, Hu Y, Ou W, Wan Y. Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1. J Transl Med. 2014;12:352.
• Zanker AA, Stargardt P, Kurzbach SC, Turrina C, Mairhofer J, Schwaminger SP, Berensmeier S. Direct capture and selective elution of a secreted polyglutamate-tagged nanobody using bare magnetic nanoparticles. Biotechnol J. 2022;17(5):e2100577.